Analyst Upgrades: VMware Analysts are weighing in today on virtualization concern VMware, Inc. (NYSE:VMW - 92.32), biopharma issue Gilead Sciences, Inc. (NASDAQ:GILD - 57.19), and Web services provider AOL, Inc. (NYSE:AOL - 33.86). Here's a quick roundup of today's bullish brokerage notes.
•A session after the start of its annual developers' meeting, VMW scored an upbeat analyst note. Specifically, ThinkEquity upped its price target on the stock to $105 from $100, and reiterated its "buy" recommendation. While VMW is no stranger to analyst affection -- the stock has earned 17 "buy" or better endorsements, compared to 10 lukewarm "holds" and not one "sell"